Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial [Phase 2]
Phase II trial evaluating combined neoadjuvant systemic therapy with PIPAC for colorectal peritoneal metastasis in patients eligible for CRS…
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer [Phase 3]
Phase 3 trial evaluating encorafenib + cetuximab with or without binimetinib versus standard therapy in BRAF V600E-mutant metastatic colorec…
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis [Phase 3]
A Phase 3 trial comparing raltitrexed-based vs 5-FU-based neoadjuvant chemotherapy for colorectal liver metastasis has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-07-08Clinical Trial Update: Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update for Olaptesed (NOX-A12) alone and with pembrolizumab in metastatic colorectal and pancreatic cancer has completed Phas…
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Fuzheng Yiliu-1010 [Phase 2]
Phase 2 clinical trial update for Fuzheng Yiliu-1010 in colorectal cancer (Stage II/III). Status not disclosed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-24Clinical Trial Update: A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC) [Phase 1, Phase 2]
Clinical trial update investigating camrelizumab for colorectal mucinous adenocarcinoma across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2020-06-22Clinical Trial Update: A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab [Phase 1]
Phase 1 study evaluating MEDI4736 (durvalumab) in combination with tremelimumab has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-18Clinical Trial Update: Cetuximab Rechallenge Study [Phase 2]
Phase 2 trial update on cetuximab rechallenge for metastatic colorectal cancer has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2020-06-17Clinical Trial Update: Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial update evaluating bevacizumab in combination with a triplet chemotherapy regimen for untreated metastatic colorectal cancer; s…
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis [Phase 3]
Phase 3 trial evaluating the efficacy of HIPEC in colorectal cancer patients at high risk for peritoneal carcinomatosis is ongoing (recruiti…
-
FDA approval · 2020-06-12FDA Approved: IRINOTECAN HYDROCHLORIDE 40 MG/2 ML — Supplemental Application (Armas Pharmaceuticals Inc.)
The FDA approved a supplemental application for irinotecan hydrochloride 40 mg/2 mL from Armas Pharmaceuticals Inc., enabling its continued …
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab [Phase 3]
A phase 3 trial evaluating 5-FU based maintenance therapy after induction with FOLFOX plus panitumumab in RAS wild-type metastatic colorecta…
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer Patients [Phase 2]
Phase 2 trial comparing metronomic capecitabine-oxaliplatin with XELOX in Egyptian metastatic colorectal cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-06-05Clinical Trial Update: Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer [Phase 2]
Phase 2 clinical trial evaluating radiation therapy and chemotherapy followed by surgery and combination chemotherapy in patients with color…
-
CLINICAL_TRIALS trial_result · 2020-06-01Clinical Trial Update: Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer [Phase 1, Phase 2]
Clinical trial update on the safety and efficacy of AMG 820 plus pembrolizumab in select advanced solid tumors (Phase 1/2; completed).
-
CLINICAL_TRIALS research · 2020-05-13Clinical Trial Update: The Efficacy of Silymarin as Adjuvant Therapy on Colorectal Cancer Patients Undergoing FOLFIRI Treatment [Phase 4]
A Phase 4 clinical trial evaluating silymarin as adjuvant therapy for patients with metastatic colorectal cancer undergoing FOLFIRI treatmen…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: JS001 Combined With Regorafenib in Patients With Advanced Colorectal Cancer [Phase 1, Phase 2]
A clinical trial update on JS001 combined with regorafenib in advanced colorectal cancer, covering Phase 1 and Phase 2 stages.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients [Phase 2]
Phase 2 trial comparing FOLFOX + Panitumumab vs 5-FU + Panitumumab in elderly patients with RAS/BRAF wild-type metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer [Phase 1, Phase 2]
Phase I/II study evaluating XELOXIRI plus bevacizumab as first-line treatment for metastatic colorectal cancer; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating safety and tolerability of Andecaliximab as monotherapy and in combination with chemotherapy in advanced solid tumo…
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy [Phase 2]
Phase 2 trial evaluating CS-7017 in combination with FOLFIRI for metastatic colorectal cancer after failure of first-line therapy; study com…
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer [Phase 3]
A Phase 3 clinical trial update on combination chemotherapy for advanced colorectal cancer has completed enrollment.
-
FDA approval · 2020-04-27FDA Approved: CAPECITABINE — Original Application (Lifestar Pharma LLC)
FDA approves the original application for a generic capecitabine tablet by Lifestar Pharma LLC. This marks the availability of a generic ver…
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Azacitidine and CAPOX in Metastatic Colorectal Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating azacitidine plus CAPOX in metastatic colorectal cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Study of Apatinib Plus S-1 as the Therapy of Advanced Colorectal Cancer [Phase 2]
Phase 2 clinical trial evaluating Apatinib plus S-1 for advanced colorectal cancer.